Bibliographic Details
| Title: |
Novo Owner Backs Italy Fund to Spur Drug Startups Beyond Denmark. |
| Authors: |
Wass, Sanne (AUTHOR) |
| Source: |
Bloomberg.com. 7/2/2026, pN.PAG-N.PAG. 1p. |
| Subject Terms: |
*Business incubators, *Pharmaceutical industry, *Biotechnology industries, *Corporate investments, *Investment policy, Life sciences |
| Geographic Terms: |
Rome, Europe |
| Abstract: |
The article focuses on Novo Holdings, the commercial arm of the Novo Nordisk Foundation, investing €5 million in a new Italian startup accelerator aimed at supporting early-stage life science companies across Europe. The Rome-based accelerator, funded initially with €25 million including contributions from the regional agency Lazio Innova, will be managed by the Copenhagen-based BioInnovation Institute, which has experience backing over a hundred startups. This initiative is part of a broader effort to transform academic research into commercial ventures, with plans to support around 20 startups over four years and expand into Germany and the UK. The project also seeks to attract private investors to further scale its impact in the European life sciences sector. [Extracted from the article] |
|
Copyright of Bloomberg.com is the property of Bloomberg, L.P. and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| Database: |
Business Source Index |